Studies of Factor VIII Inhibitors in Chinese Hemophilia a Patients

  • Ming-Ching Shen
  • Shu-Wha Lin
  • Pei-Chu Yang
  • Chin-Chin Huang
Conference paper


It has been recognized that hemophilic patients with clotting factor inhibitors bleed no more frequently and no worse than patients who do not have this complication. However, the management of bleeding in these patients is a major problem. Low responders can be treated effectively with high doses of clotting factor, whereas treatment is difficult when the clotting factor inhibitor titer is high. Therefore, the diagnosis of the presence of clotting factor inhibitor, immunologic characterization of the inhibitor and investigation of the interaction of the inhibitor with clotting factor become very important in the management of the hemophiliacs with inhibitor[1]. Recent advances in the development of gene cloning and expression have made it possible to characterize in detail, the epitopes recognized by inhibitors. This epitope mapping helps us to understand the structure and function relationship of factor VIII protein and also the mechanism by which these factor VIII inhibitors react[2,3]. This paper is to present the immunologic characterization and kinetic studies of factor VIII inhibitors found in six patients and epitope mapping of one of the inhibitors.


Factor VIII Thrombin Activation Hemophilic Patient Translate Amino Acid Sequence Immunologic Characterization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Shen MC (1982) J Formosan Med Assoc 81: 364–379Google Scholar
  2. 2.
    Ware J, Toomey JR, Stafford DW (1988) Proc Natl Acad Sci USA 85: 3165–3169PubMedCrossRefGoogle Scholar
  3. 3.
    Lubahn BC, Ware J, Staffrod DW, Reisner HM (1989) Blood 73: 497–499PubMedGoogle Scholar
  4. 4.
    Lossing TS, Kasper CK, Feinstein DI (1977) Blood 49: 793–797PubMedGoogle Scholar
  5. 5.
    Kasper CK, Aledort LM, Counts RB, Edson JR, Fratantoni J, Green D, Hampton JW, Hilgartner MW, Lazerson J, Levine PH, McMillan CW, Poul JG, Shapiro SS, Shulman NR, Van Eys J (1975) Thromb Diath Haemorrh 34: 869–872Google Scholar
  6. 6.
    Kasper CK (1975) Thromb Diath Haemorrh 34: 875–876PubMedGoogle Scholar
  7. 7.
    Feinstein DI, Rapaport SI, Chong MNY (1969) Blood 34: 85–90PubMedGoogle Scholar
  8. 8.
    Biggs R, Austen DEG, Denson KWE, Rizza CR, Borrett R (1972) Br J Haematol 23: 125–135PubMedCrossRefGoogle Scholar
  9. 9.
    Biggs R, Austen DEG, Denson KWE, Borrett R, Rizza CR (1972) Br J Haematol 23: 137–155PubMedCrossRefGoogle Scholar
  10. 10.
    Gawryl MS, Hoyer LW (1982) Blood 60: 1103–1109PubMedGoogle Scholar
  11. 11.
    Maniatis T, Fritsch EF, Sambrook J (1989) Molecular cloning: a laboratory manual, Cold Spring Harbor Laboratory. Cold spring Habor, New YorkGoogle Scholar
  12. 12.
    Messing J (1983) Methods in enzymology 101: 20–89PubMedCrossRefGoogle Scholar
  13. 13.
    Sanger F, Nichlen S, Coulson AR (1977) Proc Natl Acad Sci USA 74: 5463–5467PubMedCrossRefGoogle Scholar
  14. 14.
    Hoyer LW, Gawryl MS, Fuente Bdl (1984) In: Hoyer LW (eds) Progress in clinical and biological research volume 150, Factor VIII inhibitors Alan R Liss, Inc New York. pp. 73–89Google Scholar
  15. 15.
    White II GC, Shoemaker CB (1989) Blood 73: 1–12PubMedGoogle Scholar
  16. 16.
    Foster PA, Fulcher CA, Houghten RA, Mahoney SDG, Zimmerman TS (1988) J Clin Invest 82: 123–128PubMedCrossRefGoogle Scholar
  17. 17.
    Nilsson IM, Freiburghaus C, Sundqvist SB, Sandberg H (1984) Plasma Ther Transfus Technol 5: 127Google Scholar

Copyright information

© Springer Japan 1993

Authors and Affiliations

  • Ming-Ching Shen
    • 1
  • Shu-Wha Lin
    • 1
  • Pei-Chu Yang
    • 1
  • Chin-Chin Huang
    • 1
  1. 1.Department of Laboratory Medicine and Graduate Institute of Medical Technology, College of MedicineNational Taiwan UniversityTaipeiTaiwan, Republic of China

Personalised recommendations